GW PHARMACEUTICALS PLC Selling, General and Administrative Expense
GW PHARMACEUTICALS PLC reported Selling, General and Administrative Expense of $101.05 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2021-05-03
- GW PHARMACEUTICALS PLC selling, general and administrative expense for the quarter ending 2021-03-31 was $101.05M, a 41.96% increase year-over-year.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for the quarter ending 2020-12-31 was $103.76M, a 32.43% increase year-over-year.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for the quarter ending 2020-09-30 was $85.20M, a 32.76% increase year-over-year.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for the quarter ending 2020-06-30 was $75.89M, a 21.87% increase year-over-year.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for fiscal 2020 was $336.04M, a 29.31% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for fiscal 2019 was $259.88M.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for fiscal 2018 was $141.82M, a 144.43% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC selling, general and administrative expense for fiscal 2017 was $58.02M, a 74.82% increase from fiscal 2016.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $101.05M 10-Q · filed 2021-05-03 | $204.81M derived: sum of 2 quarters · filed 2021-05-03 | $290.02M derived: sum of 3 quarters · filed 2021-05-03 | $365.91M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $103.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $188.97M derived: sum of 2 quarters · filed 2021-02-26 | $264.86M derived: sum of 3 quarters · filed 2021-02-26 | $336.04M 10-K · filed 2021-02-26 |
| 2020-09-30 | $85.20M 10-Q · filed 2020-11-05 | $161.10M derived: sum of 2 quarters · filed 2020-11-05 | $232.28M 10-Q · filed 2020-11-05 | $310.63M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $75.89M 10-Q · filed 2020-08-07 | $147.08M 10-Q · filed 2020-08-07 | $225.43M derived: sum of 3 quarters · filed 2021-05-03 | $289.61M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $71.18M 10-Q · filed 2021-05-03 | $149.53M derived: sum of 2 quarters · filed 2021-05-03 | $213.71M derived: sum of 3 quarters · filed 2021-05-03 | $275.99M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $78.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $142.53M derived: sum of 2 quarters · filed 2021-02-26 | $204.80M derived: sum of 3 quarters · filed 2021-02-26 | $259.88M 10-K · filed 2021-02-26 |
| 2019-09-30 | $64.18M 10-Q · filed 2020-11-05 | $126.45M derived: sum of 2 quarters · filed 2020-11-05 | $181.53M 10-Q · filed 2020-11-05 | $230.61M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $62.27M 10-Q · filed 2020-08-07 | $117.35M 10-Q · filed 2020-08-07 | $166.43M derived: sum of 3 quarters · filed 2021-02-26 | $219.12M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $55.08M 10-Q · filed 2020-05-11 | $104.16M derived: sum of 2 quarters · filed 2021-02-26 | $156.85M derived: sum of 3 quarters · filed 2021-02-26 | $194.63M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $49.08M 10-K · filed 2021-02-26 | $101.77M derived: sum of 2 quarters · filed 2021-02-26 | $139.55M derived: sum of 3 quarters · filed 2021-02-26 | $165.73M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $52.69M 10-Q · filed 2019-11-06 | $90.47M derived: sum of 2 quarters · filed 2019-11-06 | $116.64M 10-Q · filed 2019-11-06 | $141.82M 10-K · filed 2021-02-26 |
| 2018-06-30 | $37.79M 10-Q · filed 2019-08-07 | $63.96M 10-Q · filed 2019-08-07 | $89.13M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | $26.17M 10-Q · filed 2019-05-08 | $51.35M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $25.17M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $58.02M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $33.19M 10-KT · filed 2019-02-28 |